Augmenting Language Therapy for Aphasia: Levodopa

Completed

Phase 2/3 Results

Summary of Purpose

The purpose of this study is to evaluate the effectiveness of the medication levodopa, in combination with speech-language treatment, on the language outcome of study subjects with nonfluent aphasia (i.e. difficulty with the comprehension and expression of spoken and written language) following a stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 27 November 2013.

1 Oct 2007 2 Aug 2011 1 Mar 2012 1 Mar 2012 1 Nov 2013 5 Jun 2013
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • Leora R Cherney, Ph.D.

  • Rosalind C Kaye, Ph.D.

    rkaye@ric.org 312-238-6163